Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism PGAP3 modulators(post-GPI attachment to proteins phospholipase 3 modulators), Gene modulators |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Disorders of Glycosylation | Preclinical | US | 08 May 2024 | |
Congenital Disorders of Glycosylation | Preclinical | US | 08 May 2024 |